Business Description
DuoGenic StemCells Corp
NAICS : 541714
SIC : 2834
ISIN : TW0007607004
Description
DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.94 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | -0.14 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 29.82 | |||||
| Beneish M-Score | -2.34 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.79 | |||||
| 9-Day RSI | 25.56 | |||||
| 14-Day RSI | 31.7 | |||||
| 6-1 Month Momentum % | -8.71 | |||||
| 12-1 Month Momentum % | -9.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.73 | |||||
| Quick Ratio | 3.21 | |||||
| Cash Ratio | 2.27 | |||||
| Days Inventory | 321.33 | |||||
| Days Sales Outstanding | 128.37 | |||||
| Days Payable | 5.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.36 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 26.69 | |||||
| Operating Margin % | -487.09 | |||||
| Net Margin % | -485.18 | |||||
| FCF Margin % | -408.09 | |||||
| ROE % | -73.68 | |||||
| ROA % | -62.44 | |||||
| ROIC % | -149.97 | |||||
| ROC (Joel Greenblatt) % | -175.1 | |||||
| ROCE % | -70.12 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 73.33 | |||||
| PB Ratio | 18.21 | |||||
| Price-to-Tangible-Book | 18.71 | |||||
| EV-to-EBIT | -14.74 | |||||
| EV-to-EBITDA | -16.92 | |||||
| EV-to-Revenue | 72.19 | |||||
| EV-to-FCF | -17.66 | |||||
| Price-to-Net-Current-Asset-Value | 42.97 | |||||
| Price-to-Net-Cash | 125 | |||||
| Earnings Yield (Greenblatt) % | -6.79 | |||||
| FCF Yield % | -5.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DuoGenic StemCells Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 11.452 | ||
| EPS (TTM) (NT$) | -1.83 | ||
| Beta | 0 | ||
| Volatility % | 24.43 | ||
| 14-Day RSI | 31.7 | ||
| 14-Day ATR (NT$) | 0.829096 | ||
| 20-Day SMA (NT$) | 29.3 | ||
| 12-1 Month Momentum % | -9.75 | ||
| 52-Week Range (NT$) | 26.3 - 39.4 | ||
| Shares Outstanding (Mil) | 30.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DuoGenic StemCells Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DuoGenic StemCells Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
DuoGenic StemCells Corp Frequently Asked Questions
What is DuoGenic StemCells Corp(ROCO:7607)'s stock price today?
The current price of ROCO:7607 is NT$27.50. The 52 week high of ROCO:7607 is NT$39.40 and 52 week low is NT$26.30.
When is next earnings date of DuoGenic StemCells Corp(ROCO:7607)?
The next earnings date of DuoGenic StemCells Corp(ROCO:7607) is .
Does DuoGenic StemCells Corp(ROCO:7607) pay dividends? If so, how much?
DuoGenic StemCells Corp(ROCO:7607) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers